Harmony Biosciences Holdings Inc (HRMY)
34.06
-0.89
(-2.55%)
USD |
NASDAQ |
Dec 24, 16:00
Harmony Biosciences Holdings Free Cash Flow: 220.18M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Regeneron Pharmaceuticals Inc | 3.319B |
| Dyne Therapeutics Inc | -244.42M |
| Arrowhead Pharmaceuticals Inc | -604.32M |
| Incyte Corp | 16.80M |
| EyePoint Pharmaceuticals Inc | -118.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 70.50M |
| Cash from Investing (Quarterly) | 0.745M |
| Cash from Financing (Quarterly) | -1.175M |
| Free Cash Flow Per Share (Quarterly) | 1.213 |
| Free Cash Flow to Equity (Quarterly) | 74.07M |
| Free Cash Flow to Firm (Quarterly) | 70.50M |
| Free Cash Flow Yield | 11.14% |